Lupus clinical research study

Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that can affect various parts of the body, including the skin, joints, kidneys, and other organs. It is estimated that about 5 million people worldwide suffer from lupus, and it is more common in women than men. Symptoms can vary widely from person to person and can include joint pain, skin rashes, fever, fatigue, and kidney problems. There is no cure for SLE, but treatment can help manage the symptoms and prevent damage to the organs. Treatment options may include medications, lifestyle changes, and in some cases, surgery.

CRP is now enrolling participants with moderate to severe lupus for a clinical trial exploring the safety and efficacy of a new investigational drug

Get started now

  • People diagnosed with SLE 

  • Between 18-75 years of age (inclusive)

  • Taking at least one SLE treatment (e.g. Hydroxychloroquine)

Who is it for?

  • Study-related medication

  • Exams & lab work at no cost

  • If you qualify, you may be compensated for time and travel

Benefits for participants

       
   
   
   
   
   
       
                                   

Don’t see what you’re looking for?